fludarabine has been researched along with Vision, Diminished in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stanford, M; Virgo, J; Williams, G | 1 |
Azlin, I; Fadilah, SA; Muhaya, M | 1 |
Ascaso, FJ; Fuertes, MA; Jimenez, B; Keane, PA; Sadda, S | 1 |
3 other study(ies) available for fludarabine and Vision, Diminished
Article | Year |
---|---|
Visual loss secondary to fludarabine toxicity: optical coherence tomography findings in two patients.
Topics: Antineoplastic Agents; Follow-Up Studies; Hematologic Neoplasms; Humans; Prognosis; Retina; Tomography, Optical Coherence; Vidarabine; Vision, Low; Visual Acuity; Visual Field Tests; Visual Fields | 2019 |
Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Male; Optic Nerve; Optic Nerve Diseases; Plasmapheresis; Prognosis; Retinal Vein; Risk Factors; Rituximab; Vidarabine; Vision, Low; Visual Acuity; Waldenstrom Macroglobulinemia | 2007 |
Diagnostic and therapeutic challenges.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymph Nodes; Male; Middle Aged; Retinal Neoplasms; Rituximab; Splenomegaly; Tomography, X-Ray Computed; Vidarabine; Vision, Low; Visual Acuity; Vitreoretinopathy, Proliferative; Vitreous Hemorrhage | 2011 |